
No data
No data
No data
| CAS Number | 32780-64-6 |
| Catalog Number | AG0038TR(AGN-PC-0R85PC) |
| Chemical Name | 2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl |
| IUPAC Name | 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride |
| InChI | InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H |
| InChI Key | WQVZLXWQESQGIF-UHFFFAOYSA-N |
| MDL Number | MFCD00057663 |
| Molecular Formula | C19H25ClN2O3 |
| Molecular Weight | 364.8664 |
| SMILES | CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=O)N)O)O.Cl |
| UNII | 1GEV3BAW9J |
| Synonyms | AH 5158,
AH-5158,
AH5158,
Albetol,
Apo Labetalol,
Apo-Labetalol,
ApoLabetalol,
Dilevalol,
Hydrochloride, Labetalol,
Labetalol,
Labetalol Hydrochloride,
Labetalol, (R,R)-Isomer,
Labetolol,
Normodyne,
Presolol,
R,R Labetalol,
R,R-Labetalol,
SCH 19927,
SCH-19927,
SCH19927,
Trandate,
Labetalol hydrochloride,
32780-64-6,
Labetalol HCL,
Amipress,
Presdate,
Labrocol,
Pressalolo,
Ipolab,
Labetalol (hydrochloride),
2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride,
UNII-1GEV3BAW9J,
AH 5158A,
Sch-15719W,
ScH 15719W,
CCRIS 1086,
Labetalol hydrochloride,
EINECS 251-211-1,
1GEV3BAW9J,
NSC 290312,
MLS000069666,
AH-5158A,
MFCD00057663,
SMR000058463,
5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride,
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide hydrochloride,
2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride,
5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride,
DSSTox_CID_24654,
DSSTox_RID_80378,
Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride,
DSSTox_GSID_44654,
C19H25ClN2O3,
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride,
Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride,
Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1),
AH-5158,
SR-01000000209,
C19H24N2O3.HCl,
labetalol-hcl,
2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride,
2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide hydrochloride,
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride,
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride,
Normodyne (TN),
Trandate (TN),
Prestwick_290,
EINECS 276-694-6,
Labetalol hydrochloride [USAN:JAN],
Labetalol hydrochloride [USAN:USP:JAN],
AC1Q5DEI,
AH-5158 hydrochloride,
La.beta.lol hydrochloride,
Opera_ID_1625,
Benzamide,monohydrochloride,
NCGC00016810-01,
Salicylamide, hydrochloride,
CAS-32780-64-6,
SCHEMBL41230,
MLS001148626,
MLS002222197,
SPECTRUM1503243,
AC1L2G48,
CHEBI:6344,
CHEMBL1200323,
DTXSID0044654,
CTK4G9285,
KS-00000GGU,
AOB5072,
WQVZLXWQESQGIF-UHFFFAOYSA-N,
HMS1568H16,
HMS1922M13,
Pharmakon1600-01503243,
BCP13886,
HY-B1108,
Tox21_110623,
Tox21_302725,
Tox21_500687,
CCG-40314,
Labetalol hydrochloride (JP17/USP),
NSC290312,
NSC758438,
s4291,
AKOS015895575,
AC-1389,
API0003104,
CS-4706,
LP00687,
NC00571,
NSC-290312,
NSC-758438,
SS-4219,
VA11135,
NCGC00094044-01,
NCGC00094044-02,
NCGC00094044-03,
NCGC00094044-04,
NCGC00094044-05,
NCGC00256847-01,
NCGC00261372-01,
(R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride,
72487-34-4,
AK144692,
AN-14950,
BC678573,
CPD000058463,
Labetalol HCl (Mixture of Diastereomers),
LS-26937,
SAM002564217,
SC-58270,
AX8135749,
ST2410032,
4CH-016313,
EU-0100687,
FT-0630564,
SW196595-3,
D00600,
J10319,
Labetalol hydrochloride, >98% (TLC), powder,
780L646,
C-20992,
I06-0868,
SR-01000000209-2,
SR-01000000209-7,
2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl,
2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl,
Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard,
2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide hydrochloride,
Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-,monohydrochloride,
Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1),
Normodyne,
Trandate,
NORMOZIDE,
Dilevalol hydrochloride,
labetolol Hydrochloride,
TRANDATE HCT,
Benzamide, monohydrochloride,
C19H24N2O3.ClH,
CID71412,
C19-H24-N2-O3.Cl-H,
AR-1G6710,
CL0011,
32780-64-6 (HCl),
L 1011,
(R*,R*)-(+-)-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride,
33588-16-8,
Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, monohydrochloride,
|
| Complexity | 385 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 364.155g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 364.87g/mol |
| Monoisotopic Mass | 364.155g/mol |
| Rotatable Bond Count | 8 |
| Topological Polar Surface Area | 95.6A^2 |
| Undefined Atom Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

